Cobalis Signs Exclusive International Broker Agreement for Eastern Europe and Secures US$20 Million Purchase Order
11 Mars 2010 - 3:45PM
PR Newswire (US)
IRVINE, Calif., March 11 /PRNewswire-FirstCall/ -- Cobalis
Corporation (Pink Sheets: CLSC) announced today that it has
executed an exclusive international broker agreement covering sales
of the Company's flagship anti-allergy product PreHistin, with EXIM
Intertrading Bancorp. The agreement provides EXIM a four year
exclusivity to represent and solicit purchase orders for PreHistin
in most countries of the former Soviet Union, and throughout most
countries of the former Yugoslavia. As part of the terms of the
agreement, EXIM has secured for Cobalis a bank-guaranteed purchase
order for the sale of PreHistin to OC STROYPROEKT, a Moscow based
pharmaceutical and healthcare product marketer. The terms of the
purchase order call for delivery by Cobalis of the complete
quantity ordered via the firm purchase order by January 31, 2011
with a total purchase price of US$20,000,000. The purchase order is
irrevocably guaranteed on behalf of OC STROYPROEKT by SBERBANK, the
largest bank in Russia, payable upon delivery of PreHistin over the
next 11 months. "PreHistin ®, The World's FIRST
Pre-Histamine"(TM) is different than current allergy anti-histamine
treatments which are designed to treat symptoms after they occur.
PreHistin works to modulate the immune response to allergens to
give allergy sufferers a normal (non-reactive) response when
exposed to allergens. It has been shown that in as little as a few
weeks, allergy sufferers can experience significant reduction in
nasal symptoms, as well as reductions in IgE levels that have been
shown to lead to the body's release of symptom-causing histamine.
Chas Radovich, Cobalis President said, "This landmark international
broker agreement and bank-guaranteed purchase order represents the
most significant confirmation possible for the ability of Cobalis
to bring PreHistin to market on a worldwide basis. The Tier 1 Bank
Guarantee from SBERBANK behind this US$20 Million purchase order
from OC STROYPROEKT gives Cobalis the platform and financial
stability to move forward and achieve the profitability potential
for PreHistin the Company has been preparing for. The timing could
not be better to begin our international PreHistin sales while we
simultaneously prepare to brand PreHistin by launching our US
Direct Response Television and Internet advertising campaign this
month." ABOUT COBALIS CORP -- PREHISTIN ® Cobalis Corp. is an
over the counter pharmaceutical and nutraceutical development
company. Its flagship product, "PreHistin ®, The World's FIRST
Pre-Histamine"(TM), is designed to mitigate overproduction of IgE
levels, to restore normal response to seasonal and year-round
indoor and outdoor allergens and reduce the likelihood of onset of
allergy symptoms resulting from histamine release. PreHistin ®
is available without prescription for both long-term and daily use.
For PreHistin ® product information and ordering please visit
at http://www.prehistin.com/ or call toll free 1-877-4POLLEN. For
additional company information please visit their website at
http://www.cobalis.com/ ABOUT SBERBANK Established in 1841,
SBERBANK (Savings Bank of The Russian Federation) currently is the
largest credit institution in Russia and CIS, accounting for about
a quarter of the aggregate Russian banking assets and a third of
banking capital. According to The Banker magazine, as of July 1,
2009, SBERBANK was ranked 38th in the world in terms of Tier 1
capital. Contact: Cobalis Corporation 2030 Main St. Suite 1300
Irvine, CA 92614 949-260-9007 Chas Radovich info@cobalis.com
info@prehistin.com DATASOURCE: Cobalis Corporation CONTACT: Chas
Radovich of Cobalis Corporation, +1-949-260-9007,info@cobalis.com
or info@prehistin.com Web Site: http://www.cobalis.com/
Copyright
Cheerful Scout (LSE:CLS)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Cheerful Scout (LSE:CLS)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
Real-Time news about Cheerful Scout (London Stock Exchange): 0 recent articles
Plus d'articles sur Cheerful Scout